Abstract Details
|
Ali R. Shoraka, MD
(University of Texas At Houston)
PRESENTER |
No disclosure on file |
| No disclosure on file | |
| Eduardo M. Zilli, MD (UT Health, San Antonio) | Dr. Zilli has nothing to disclose. |
| Glen R. Finney, MD, FAAN (Geisinger Health) | Dr. Finney has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Premier Inc. Dr. Finney has a non-compensated relationship as a Board Member with Greater Pennsylvania Chapter of the Alzheimer's Association that is relevant to AAN interests or activities. |
| No disclosure on file | |
| Kenneth M. Heilman, MD, FAAN (Univ. of Florida, Dept. of Neurology) | Dr. Heilman has received publishing royalties from a publication relating to health care. |
| Adam D. Falchook, MD (Alzheimer's Research and Treatment Center) | No disclosure on file |
| Shannon Kolind, PhD, MSc, BSc (University of British Columbia) | Dr. Kolind has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Kolind has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Dr. Kolind has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dr. Kolind has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Roche. The institution of Dr. Kolind has received research support from Sanofi Genzyme. The institution of Dr. Kolind has received research support from Roche. The institution of Dr. Kolind has received research support from Biogen. |